Diagnostic Criteria and Treatment Options for Acute Liver Failure
Acute liver failure (ALF) is defined by the presence of coagulopathy and any degree of altered mental status in a patient without pre-existing liver disease, with illness duration ≤26 weeks. 1
Diagnostic Criteria
Definition and Classification
- ALF is characterized by rapid loss of functional hepatocytes in patients with no evidence of pre-existing liver disease 2
- The diagnostic criteria include:
Initial Laboratory Evaluation
- Complete blood count and ferritin levels should be obtained at baseline 4
- Comprehensive metabolic panel including liver function tests (AST, ALT, alkaline phosphatase, total and direct bilirubin) 4, 1
- Coagulation studies (prothrombin time/INR) 1
- Renal function tests (creatinine, BUN, eGFR) 4
- Arterial blood gases and lactate 1
- Acetaminophen level and toxicology screen 1
- Viral hepatitis serologies 1
Imaging and Additional Testing
- Abdominal ultrasound is recommended as the first-line imaging test 5
- Transjugular liver biopsy may be helpful when etiology remains unclear after routine evaluation 4
- Neurological evaluation is often useful between attacks for assessment of positive neurological findings 4
Etiology-Specific Treatment Options
Acetaminophen-Induced ALF
- N-acetylcysteine (NAC) should be administered immediately at a loading dose of 140 mg/kg orally or via nasogastric tube followed by 70 mg/kg every 4 hours for 17 doses 1, 6
- NAC treatment should be initiated even if >48 hours since ingestion 1
Viral Hepatitis
- For hepatitis A and B-related ALF, supportive care is recommended as no virus-specific treatment has proven effective 1
- For patients with suspected herpes virus or varicella zoster as the cause of ALF, immediate acyclovir treatment is recommended 1
Wilson Disease
- Wilson disease-related ALF is considered uniformly fatal without transplantation 1
- Treatment to acutely lower serum copper and limit hemolysis should include albumin dialysis, continuous hemofiltration, plasmapheresis, or plasma exchange 1
- Penicillamine is not recommended in ALF due to risk of hypersensitivity 1
Autoimmune Hepatitis
- Liver biopsy should be considered to establish a diagnosis 1
- Treatment with corticosteroids (prednisone, 40-60 mg/day) is recommended 1
- Patients should be placed on the transplant list even while corticosteroids are being administered 1
Drug-Induced Hepatotoxicity
- Discontinue all but essential medications 1
- Obtain a detailed medication history including prescription drugs, non-prescription medications, herbs, and dietary supplements 1
Mushroom Poisoning
- Consider administration of penicillin G and silymarin 1
- Patients should be listed for transplantation, as this procedure is often the only lifesaving option 1
Supportive Care Management
Hemodynamic Support
- Careful attention must be paid to fluid resuscitation and maintenance of adequate intravascular volume 1
- If fluid replacement fails to maintain mean arterial pressure of 50-60 mm Hg, use systemic vasopressor support with agents such as epinephrine, norepinephrine, or dopamine (but not vasopressin) 1
Metabolic Management
- Manage hypoglycemia with continuous glucose infusions 1
- Monitor and supplement phosphate, magnesium, and potassium levels as needed 1
- Initiate enteral feedings early with moderate protein intake (approximately 60 grams per day) 1
Central Nervous System Management
- For grades III-IV encephalopathy, intubation is recommended for airway protection 1
- Control of seizures with phenytoin is advised, while avoiding benzodiazepines when possible 1
Coagulation Management
- Administration of vitamin K is recommended 1
- Fresh frozen plasma (FFP) should be reserved for invasive procedures or active bleeding 1
- Platelets should be given for counts <10,000/mm³ or before invasive procedures 1
Renal Support
- If dialysis support is needed for acute renal failure, use continuous modes rather than intermittent modes 1
- Nephrotoxic agents should be avoided 1
Liver Transplantation
- Urgent hepatic transplantation is indicated in ALF where prognostic indicators suggest a high likelihood of death 1
- Post-transplant survival rates for ALF have been reported as high as 80% to 90% 1
- Poor prognostic indicators include idiosyncratic drug injury, non-hepatitis A viral infections, autoimmune hepatitis, mushroom poisoning, Wilson disease, Budd-Chiari syndrome, and indeterminate cause 1
Common Pitfalls and Caveats
- Changes in aminotransferase levels correlate poorly with prognosis in ALF patients 1
- Malignant infiltration of the liver can mimic ALF and should be considered in patients with previous cancer history or massive hepatomegaly 4
- Systemic corticosteroids are ineffective for general ALF treatment, except in autoimmune hepatitis 1
- Sorbent systems may show transient improvement of hepatic encephalopathy but no improvement in hepatic function or long-term benefit 1